Clinical stage biotechnology company Aphios has obtained notification of allowance(NOA)from the US Patent and Trademark Office(USPTO)for its patent application for oral delivery of insulin. The patent entitled'Polymer ...
Tags: Aphios, USPTO, oral delivery of insulin, NOA